CareLit · DOI-Nachweis · Aktuelle Neurologie
Multi-national, multi-center, randomised, double-blind, active controlled trial to compare efficacy and tolerability of cabergoline and levodopa in patients with severe restless legs syndrome
DOI 10.1055/s-2005-919538
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Trenkwalder, L Grothe, V Otto, H Sommer, S Happe, K Schlinsog, H Vogel, H Benes
ZeitschriftAktuelle Neurologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Dopaminergic drugs are considered as the main therapeutic option for patients with a Restless Legs Syndrome (RLS). However, no clinical trial with sufficient statistical power has been conducted up to now which compared efficacy and tolerability of two active dopaminergic treatments. We report here the results on the secondary outcome measures of the first large-scale double-blind, randomized study to…
Zitieren
Zitierempfehlung
C Trenkwalder, L Grothe, V Otto, H Sommer, S Happe, K Schlinsog, H Vogel, H Benes (2005) Multi-national, multi-center, randomised, double-blind, active controlled trial to compare efficacy and tolerability of cabergoline and levodopa in patients with severe restless legs syndrome. Aktuelle Neurologie (10). https://doi.org/10.1055/s-2005-919538
Mit CareLit weiterarbeiten